nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—ABCB1—Estramustine—prostate cancer	0.152	0.2	CbGbCtD
Triflupromazine—ABCB1—Cabazitaxel—prostate cancer	0.1	0.132	CbGbCtD
Triflupromazine—ABCB1—Estrone—prostate cancer	0.0979	0.129	CbGbCtD
Triflupromazine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0872	0.115	CbGbCtD
Triflupromazine—ABCB1—Conjugated Estrogens—prostate cancer	0.064	0.0843	CbGbCtD
Triflupromazine—ABCB1—Mitoxantrone—prostate cancer	0.0582	0.0767	CbGbCtD
Triflupromazine—ABCB1—Estradiol—prostate cancer	0.0562	0.074	CbGbCtD
Triflupromazine—ABCB1—Prednisone—prostate cancer	0.0483	0.0637	CbGbCtD
Triflupromazine—ABCB1—Etoposide—prostate cancer	0.0367	0.0483	CbGbCtD
Triflupromazine—ABCB1—Docetaxel—prostate cancer	0.0336	0.0442	CbGbCtD
Triflupromazine—ABCB1—Doxorubicin—prostate cancer	0.025	0.033	CbGbCtD
Triflupromazine—Dimetacrine—ACHE—prostate cancer	0.00168	0.111	CrCbGaD
Triflupromazine—Perphenazine—AOX1—prostate cancer	0.00108	0.0714	CrCbGaD
Triflupromazine—Acepromazine—SLC22A1—prostate cancer	0.000599	0.0397	CrCbGaD
Triflupromazine—Diltiazem—CYP3A5—prostate cancer	0.000586	0.0388	CrCbGaD
Triflupromazine—Thioproperazine—SLC22A1—prostate cancer	0.000585	0.0388	CrCbGaD
Triflupromazine—Pipotiazine—SLC22A1—prostate cancer	0.000576	0.0382	CrCbGaD
Triflupromazine—Desipramine—SLC22A3—prostate cancer	0.000511	0.0338	CrCbGaD
Triflupromazine—Clomipramine—GSTP1—prostate cancer	0.000492	0.0326	CrCbGaD
Triflupromazine—Perphenazine—CYP2C18—prostate cancer	0.000482	0.032	CrCbGaD
Triflupromazine—Desipramine—CYP2C18—prostate cancer	0.000448	0.0297	CrCbGaD
Triflupromazine—Cinacalcet—CYP3A4—prostate cancer	0.000433	0.0287	CrCbGaD
Triflupromazine—Imipramine—SLC22A3—prostate cancer	0.000433	0.0287	CrCbGaD
Triflupromazine—Diltiazem—CYP2C19—prostate cancer	0.000399	0.0264	CrCbGaD
Triflupromazine—Imipramine—CYP2C18—prostate cancer	0.00038	0.0252	CrCbGaD
Triflupromazine—Desipramine—SLC22A1—prostate cancer	0.000366	0.0243	CrCbGaD
Triflupromazine—Alimemazine—CYP3A4—prostate cancer	0.000328	0.0218	CrCbGaD
Triflupromazine—Pipotiazine—CYP2C19—prostate cancer	0.000316	0.021	CrCbGaD
Triflupromazine—Chlorpromazine—SLC22A1—prostate cancer	0.000312	0.0207	CrCbGaD
Triflupromazine—Imipramine—SLC22A1—prostate cancer	0.00031	0.0206	CrCbGaD
Triflupromazine—Desipramine—CYP2A6—prostate cancer	0.000286	0.019	CrCbGaD
Triflupromazine—Mequitazine—CYP3A4—prostate cancer	0.000283	0.0187	CrCbGaD
Triflupromazine—Fluphenazine—CYP2E1—prostate cancer	0.000276	0.0183	CrCbGaD
Triflupromazine—Diltiazem—CYP3A4—prostate cancer	0.000254	0.0168	CrCbGaD
Triflupromazine—Clomipramine—CYP2C19—prostate cancer	0.00025	0.0166	CrCbGaD
Triflupromazine—Thioridazine—CYP2E1—prostate cancer	0.000238	0.0158	CrCbGaD
Triflupromazine—Thioridazine—CYP2C19—prostate cancer	0.000235	0.0156	CrCbGaD
Triflupromazine—Desipramine—ADRB2—prostate cancer	0.000234	0.0155	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2E1—prostate cancer	0.000227	0.015	CrCbGaD
Triflupromazine—Perphenazine—CYP2C19—prostate cancer	0.000216	0.0143	CrCbGaD
Triflupromazine—Desipramine—CYP2E1—prostate cancer	0.000203	0.0135	CrCbGaD
Triflupromazine—Desipramine—CYP2C19—prostate cancer	0.000201	0.0133	CrCbGaD
Triflupromazine—Pipotiazine—CYP3A4—prostate cancer	0.000201	0.0133	CrCbGaD
Triflupromazine—Promazine—CYP2C19—prostate cancer	0.000195	0.0129	CrCbGaD
Triflupromazine—Prochlorperazine—CYP3A4—prostate cancer	0.000192	0.0127	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2E1—prostate cancer	0.000173	0.0115	CrCbGaD
Triflupromazine—Imipramine—CYP2E1—prostate cancer	0.000172	0.0114	CrCbGaD
Triflupromazine—Imipramine—CYP2C19—prostate cancer	0.000171	0.0113	CrCbGaD
Triflupromazine—Clomipramine—CYP3A4—prostate cancer	0.000159	0.0105	CrCbGaD
Triflupromazine—Perphenazine—CYP3A4—prostate cancer	0.000137	0.00911	CrCbGaD
Triflupromazine—Desipramine—CYP3A4—prostate cancer	0.000128	0.00848	CrCbGaD
Triflupromazine—Promazine—CYP3A4—prostate cancer	0.000124	0.00821	CrCbGaD
Triflupromazine—Chlorpromazine—CYP3A4—prostate cancer	0.000109	0.00723	CrCbGaD
Triflupromazine—Imipramine—CYP3A4—prostate cancer	0.000108	0.00719	CrCbGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL2—prostate cancer	1.87e-05	8.27e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CD—prostate cancer	1.86e-05	8.26e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CB—prostate cancer	1.86e-05	8.25e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TERT—prostate cancer	1.86e-05	8.24e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PIK3CA—prostate cancer	1.85e-05	8.19e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—prostate cancer	1.84e-05	8.18e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SERPINE1—prostate cancer	1.84e-05	8.17e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL2—prostate cancer	1.84e-05	8.17e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TERT—prostate cancer	1.84e-05	8.14e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—KRAS—prostate cancer	1.83e-05	8.09e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HIF1A—prostate cancer	1.82e-05	8.06e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—JAK2—prostate cancer	1.81e-05	8.04e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—RXRA—prostate cancer	1.81e-05	8.03e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGF2—prostate cancer	1.79e-05	7.91e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HIF1A—prostate cancer	1.78e-05	7.88e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PIK3CA—prostate cancer	1.78e-05	7.88e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—prostate cancer	1.77e-05	7.86e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MDM2—prostate cancer	1.77e-05	7.85e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOS3—prostate cancer	1.76e-05	7.8e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CAV1—prostate cancer	1.76e-05	7.79e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HIF1A—prostate cancer	1.76e-05	7.78e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ERBB2—prostate cancer	1.75e-05	7.74e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—COMT—prostate cancer	1.75e-05	7.74e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KDR—prostate cancer	1.74e-05	7.7e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTP1—prostate cancer	1.74e-05	7.7e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—prostate cancer	1.74e-05	7.7e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CB—prostate cancer	1.72e-05	7.64e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CAV1—prostate cancer	1.72e-05	7.63e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—prostate cancer	1.71e-05	7.6e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—JAK2—prostate cancer	1.71e-05	7.58e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ITPR1—prostate cancer	1.71e-05	7.58e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KDR—prostate cancer	1.7e-05	7.54e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CAV1—prostate cancer	1.7e-05	7.53e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ESR1—prostate cancer	1.69e-05	7.51e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KDR—prostate cancer	1.68e-05	7.44e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CA—prostate cancer	1.68e-05	7.43e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MDM2—prostate cancer	1.67e-05	7.4e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ESR1—prostate cancer	1.66e-05	7.35e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—prostate cancer	1.66e-05	7.34e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BAD—prostate cancer	1.65e-05	7.33e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ERBB2—prostate cancer	1.65e-05	7.3e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ESR1—prostate cancer	1.64e-05	7.25e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CB—prostate cancer	1.63e-05	7.2e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BAD—prostate cancer	1.62e-05	7.17e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CDKN1B—prostate cancer	1.62e-05	7.17e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TYMS—prostate cancer	1.62e-05	7.16e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTEN—prostate cancer	1.61e-05	7.13e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APC—prostate cancer	1.6e-05	7.1e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CG—prostate cancer	1.6e-05	7.1e-05	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—prostate cancer	1.6e-05	7.09e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BAD—prostate cancer	1.6e-05	7.08e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTM1—prostate cancer	1.6e-05	7.08e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—prostate cancer	1.59e-05	7.03e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IRS1—prostate cancer	1.58e-05	7.02e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGF—prostate cancer	1.58e-05	7.02e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2—prostate cancer	1.58e-05	7.01e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—prostate cancer	1.57e-05	6.98e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APC—prostate cancer	1.57e-05	6.95e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	1.57e-05	6.95e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LPL—prostate cancer	1.57e-05	6.95e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—prostate cancer	1.56e-05	6.92e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IRS1—prostate cancer	1.55e-05	6.87e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGF—prostate cancer	1.55e-05	6.87e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APC—prostate cancer	1.55e-05	6.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.55e-05	6.86e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCND1—prostate cancer	1.54e-05	6.84e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GSK3B—prostate cancer	1.54e-05	6.81e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—EP300—prostate cancer	1.53e-05	6.8e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.53e-05	6.78e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGF—prostate cancer	1.53e-05	6.78e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CTNNB1—prostate cancer	1.53e-05	6.77e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDKN1B—prostate cancer	1.53e-05	6.76e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INS—prostate cancer	1.52e-05	6.72e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP1A1—prostate cancer	1.51e-05	6.71e-05	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—prostate cancer	1.51e-05	6.69e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GSK3B—prostate cancer	1.5e-05	6.67e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ERCC2—prostate cancer	1.5e-05	6.65e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—prostate cancer	1.5e-05	6.64e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—prostate cancer	1.49e-05	6.62e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2—prostate cancer	1.49e-05	6.61e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CDKN1A—prostate cancer	1.49e-05	6.61e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTEN—prostate cancer	1.49e-05	6.6e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—prostate cancer	1.49e-05	6.58e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CREBBP—prostate cancer	1.48e-05	6.58e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	1.48e-05	6.58e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INS—prostate cancer	1.48e-05	6.57e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—prostate cancer	1.47e-05	6.5e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INS—prostate cancer	1.46e-05	6.49e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—prostate cancer	1.46e-05	6.47e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCND1—prostate cancer	1.46e-05	6.45e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CREBBP—prostate cancer	1.45e-05	6.44e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—prostate cancer	1.45e-05	6.44e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CTNNB1—prostate cancer	1.44e-05	6.39e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—prostate cancer	1.43e-05	6.36e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	1.43e-05	6.36e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—prostate cancer	1.43e-05	6.33e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EP300—prostate cancer	1.42e-05	6.29e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAP2K1—prostate cancer	1.42e-05	6.28e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—prostate cancer	1.42e-05	6.28e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—prostate cancer	1.41e-05	6.26e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—prostate cancer	1.41e-05	6.25e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	1.41e-05	6.25e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CD—prostate cancer	1.41e-05	6.24e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CDKN1A—prostate cancer	1.41e-05	6.24e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTEN—prostate cancer	1.4e-05	6.22e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	1.39e-05	6.18e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SERPINE1—prostate cancer	1.39e-05	6.17e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	1.39e-05	6.15e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARA—prostate cancer	1.38e-05	6.13e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SRC—prostate cancer	1.38e-05	6.12e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—KRAS—prostate cancer	1.38e-05	6.11e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	1.38e-05	6.11e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—prostate cancer	1.37e-05	6.07e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	1.37e-05	6.07e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	1.36e-05	6.05e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	1.36e-05	6.04e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	1.36e-05	6.03e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—KRAS—prostate cancer	1.35e-05	5.98e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGF2—prostate cancer	1.35e-05	5.97e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	1.35e-05	5.97e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	1.35e-05	5.96e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—prostate cancer	1.35e-05	5.96e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EP300—prostate cancer	1.34e-05	5.94e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—prostate cancer	1.33e-05	5.9e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	1.33e-05	5.9e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—prostate cancer	1.33e-05	5.89e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGF2—prostate cancer	1.32e-05	5.85e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SRC—prostate cancer	1.3e-05	5.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGF2—prostate cancer	1.3e-05	5.77e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAV1—prostate cancer	1.3e-05	5.77e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—prostate cancer	1.3e-05	5.77e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—JAK2—prostate cancer	1.29e-05	5.73e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—prostate cancer	1.28e-05	5.69e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—prostate cancer	1.27e-05	5.62e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	1.27e-05	5.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—JAK2—prostate cancer	1.26e-05	5.6e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MDM2—prostate cancer	1.26e-05	5.59e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—prostate cancer	1.26e-05	5.57e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.25e-05	5.53e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ERBB2—prostate cancer	1.24e-05	5.51e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	1.24e-05	5.49e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—prostate cancer	1.24e-05	5.48e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—prostate cancer	1.23e-05	5.47e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MDM2—prostate cancer	1.23e-05	5.47e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	1.23e-05	5.44e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.22e-05	5.42e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.22e-05	5.4e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	1.22e-05	5.39e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—prostate cancer	1.21e-05	5.36e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	1.2e-05	5.32e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	1.2e-05	5.32e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.19e-05	5.25e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	1.19e-05	5.25e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.18e-05	5.23e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—prostate cancer	1.17e-05	5.17e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—prostate cancer	1.16e-05	5.16e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	1.15e-05	5.11e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.15e-05	5.1e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KRAS—prostate cancer	1.14e-05	5.07e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—prostate cancer	1.14e-05	5.06e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	1.14e-05	5.05e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.14e-05	5.05e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CA—prostate cancer	1.13e-05	5.03e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—prostate cancer	1.13e-05	5e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	1.13e-05	4.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2—prostate cancer	1.13e-05	4.99e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INS—prostate cancer	1.12e-05	4.97e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—prostate cancer	1.12e-05	4.97e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	1.11e-05	4.94e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.11e-05	4.93e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—prostate cancer	1.1e-05	4.9e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2—prostate cancer	1.1e-05	4.89e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.1e-05	4.88e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CREBBP—prostate cancer	1.1e-05	4.87e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCND1—prostate cancer	1.1e-05	4.87e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—prostate cancer	1.1e-05	4.86e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.09e-05	4.83e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2—prostate cancer	1.09e-05	4.82e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.09e-05	4.82e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.08e-05	4.8e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KRAS—prostate cancer	1.08e-05	4.78e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCND1—prostate cancer	1.08e-05	4.76e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—prostate cancer	1.07e-05	4.73e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	1.06e-05	4.72e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.06e-05	4.71e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.06e-05	4.7e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTEN—prostate cancer	1.06e-05	4.7e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.05e-05	4.66e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	1.05e-05	4.66e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—prostate cancer	1.04e-05	4.63e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.04e-05	4.62e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	1.04e-05	4.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTEN—prostate cancer	1.04e-05	4.6e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.03e-05	4.58e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.03e-05	4.57e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.03e-05	4.55e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.02e-05	4.54e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—prostate cancer	1.02e-05	4.5e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	1.01e-05	4.49e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EP300—prostate cancer	1.01e-05	4.48e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	9.99e-06	4.43e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CA—prostate cancer	9.91e-06	4.39e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EP300—prostate cancer	9.9e-06	4.39e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—prostate cancer	9.84e-06	4.36e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SRC—prostate cancer	9.83e-06	4.36e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EP300—prostate cancer	9.77e-06	4.33e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SRC—prostate cancer	9.62e-06	4.27e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—prostate cancer	9.58e-06	4.25e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—prostate cancer	9.58e-06	4.24e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SRC—prostate cancer	9.5e-06	4.21e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—prostate cancer	9.48e-06	4.2e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	9.37e-06	4.15e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—prostate cancer	9.3e-06	4.12e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—prostate cancer	9.28e-06	4.11e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—prostate cancer	9.27e-06	4.11e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	9.25e-06	4.1e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—prostate cancer	9.16e-06	4.06e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CB—prostate cancer	9.08e-06	4.03e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—prostate cancer	9e-06	3.99e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—prostate cancer	8.81e-06	3.91e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—prostate cancer	8.79e-06	3.9e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—prostate cancer	8.77e-06	3.89e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—prostate cancer	8.62e-06	3.82e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—prostate cancer	8.62e-06	3.82e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	8.6e-06	3.81e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—prostate cancer	8.58e-06	3.8e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—prostate cancer	8.51e-06	3.77e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	8.49e-06	3.76e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—prostate cancer	8.44e-06	3.74e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—prostate cancer	8.33e-06	3.69e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KRAS—prostate cancer	8.14e-06	3.61e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—prostate cancer	8.09e-06	3.59e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KRAS—prostate cancer	7.97e-06	3.53e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KRAS—prostate cancer	7.87e-06	3.49e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTEN—prostate cancer	7.85e-06	3.48e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—EP300—prostate cancer	7.49e-06	3.32e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	7.48e-06	3.32e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	7.32e-06	3.24e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—prostate cancer	7.24e-06	3.21e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	7.23e-06	3.2e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—prostate cancer	7.08e-06	3.14e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—prostate cancer	6.99e-06	3.1e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—prostate cancer	6.62e-06	2.94e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—prostate cancer	6.48e-06	2.87e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—prostate cancer	6.4e-06	2.84e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—prostate cancer	6.11e-06	2.71e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—prostate cancer	5.98e-06	2.65e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—prostate cancer	5.9e-06	2.62e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CA—prostate cancer	5.54e-06	2.45e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—prostate cancer	4.52e-06	2e-05	CbGpPWpGaD
